Inventor · disambiguated record
Nicholas M. Dean
Also filed as: DEAN NICHOLAS · DEAN NICHOLAS M · DEAN NICHOLAS MARK
54 granted patents·83 pending applications·4,281 citations·filing 1993–2019
99Inventor score
Files withISIS PHARMACEUTICALS INC74BENNETT C F10DEAN NICHOLAS M6EXCALIARD PHARMACEUTICALS INC4BENNETT C FRANK3
Top patents by PatentIndex Score
137 records- 0198US8501703B2Chimeric oligomeric compounds for modulation of splicingBENNETT C FRANK·Filed 2006·Granted Aug 6, 2013·99 cites·24 claims
- 0298US5801154AAntisense oligonucleotide modulation of multidrug resistance-associated proteinISIS PHARMACEUTICALS INC·Filed 1997·Granted Sep 1, 1998·1.6k cites·35 claims
- 0397US7148204B2Antisense modulation of bcl-x expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Dec 12, 2006·145 cites·16 claims
- 0497US5948902AAntisense oligonucleotides to human serine/threonine protein phosphatase genesUNIV SOUTH ALABAMA·Filed 1997·Granted Sep 7, 1999·219 cites·11 claims
- 0596US9157081B2Chimeric oligomeric compounds for modulation of splicingISIS PHARMACEUTICALS INC·Filed 2013·Granted Oct 13, 2015·29 cites·6 claims
- 0696US7879992B2Modification of MyD88 splicing using modified oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2006·Granted Feb 1, 2011·42 cites·27 claims
- 0796US6172216B1Antisense modulation of BCL-X expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 9, 2001·399 cites·35 claims
- 0896US6001992AAntisense modulation of novel anti-apoptotic bcl-2-related proteinsISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 14, 1999·230 cites·40 claims
- 0996US5877309AAntisense oligonucleotides against JNKISIS PHARMACEUTICALS INC·Filed 1997·Granted Mar 2, 1999·189 cites·2 claims
- 1095US6133246AAntisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 17, 2000·262 cites·3 claims
- 1193US5985558AAntisense oligonucleotide compositions and methods for the inibition of c-Jun and c-FosISIS PHARMACEUTICALS INC·Filed 1997·Granted Nov 16, 1999·101 cites·44 claims
- 1292US7759318B1Identification of novel pathways, genes and promoter motifs regulating adipogenesisISIS PHARMACEUTICALS INC·Filed 2005·Granted Jul 20, 2010·23 cites·23 claims
- 1392US6809193B2Antisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 26, 2004·33 cites·2 claims
- 1491US6136603AAntisense modulation of interleukin-5 signal transductionISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 24, 2000·72 cites·32 claims
- 1590US6214986B1Antisense modulation of bcl-x expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 10, 2001·86 cites·50 claims
- 1688US5744460ACombination for treatment of proliferative diseasesNOVARTIS AG·Filed 1996·Granted Apr 28, 1998·89 cites·12 claims
- 1787US6537973B1Oligonucleotide inhibition of protein kinase CISIS PHARMACEUTICALS INC·Filed 2001·Granted Mar 25, 2003·24 cites·18 claims
- 1887US6346416B1Antisense inhibition of HPK/GCK-like kinase expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 12, 2002·19 cites·26 claims
- 1987US6312900B1Antisense oligonucleotide compositions and methods for the modulation of activating protein 1ISIS PHARMACEUTICALS INC·Filed 1999·Granted Nov 6, 2001·59 cites·34 claims
- 2086US6436909B1Antisense inhibition of transforming growth factor-β expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 20, 2002·21 cites·14 claims
- 2186US6018042AAntitumor antisense oligonucleotidesNOVARTIS AG·Filed 1997·Granted Jan 25, 2000·81 cites·2 claims
- 2283US8252762B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2009·Granted Aug 28, 2012·5 cites·25 claims
- 2382US6180353B1Antisense modulation of daxx expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jan 30, 2001·16 cites·10 claims
- 2481US5703054AOligonucleotide modulation of protein kinase CISIS PHARMACEUTICALS INC·Filed 1993·Granted Dec 30, 1997·41 cites·21 claims
- 2581US5681747ANucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereofISIS PHARMACEUTICALS INC·Filed 1994·Granted Oct 28, 1997·37 cites·14 claims
- 2680US5885970AAntisense oligonucleotides against human protein kinase CISIS PHARMACEUTICALS INC·Filed 1995·Granted Mar 23, 1999·48 cites·41 claims
- 2776US9096851B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2012·Granted Aug 4, 2015·2 cites·51 claims
- 2876US7563885B1Modulation of Tudor-SN expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jul 21, 2009·2 cites·16 claims
- 2976US6339066B1Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase CISIS PHARMACEUTICALS INC·Filed 1997·Granted Jan 15, 2002·29 cites·42 claims
- 3076US6204055B1Antisense inhibition of Fas mediated signalingISIS PHARMACEUTICALS INC·Filed 1999·Granted Mar 20, 2001·31 cites·39 claims
- 3175US6001991AAntisense oligonucleotide modulation of MDR P-glycoprotein gene expressionISIS PHARMACEUTICALS INC·Filed 1997·Granted Dec 14, 1999·35 cites·6 claims
- 3274US7375212B2Modulation of Aurora B expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted May 20, 2008·1 cites·10 claims
- 3373US8765703B2Modification of MYD88 splicing using modified oligonucleotidesVICKERS TIMOTHY·Filed 2010·Granted Jul 1, 2014·3 cites·20 claims
- 3470US6221850B1Antisense oligonucleotide compositions and methods for the modulation of JNK proteinsISIS PHARMACEUTICALS INC·Filed 1998·Granted Apr 24, 2001·23 cites·23 claims
- 3569US5916807AAntisense oligonucleotides against human protein kinase CISIS PHARMACEUTICALS INC·Filed 1995·Granted Jun 29, 1999·25 cites·16 claims
- 3667US6653133B1Antisense modulation of Fas mediated signalingISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 25, 2003·2 cites·13 claims
- 3766US6087489AAntisense oligonucleotide modulation of human thymidylate synthase expressionISIS PHARMACEUTICALS INC·Filed 1998·Granted Jul 11, 2000·18 cites·10 claims
- 3866US5959096AAntisense oligonucleotides against human protein kinase CISIS PHARMACEUTICALS INC·Filed 1995·Granted Sep 28, 1999·20 cites·28 claims
- 3965US9173894B2Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)DEAN NICHOLAS M·Filed 2012·Granted Nov 3, 2015·1 cites·27 claims
- 4064US2020190521A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)DEAN NICHOLAS M·Filed 2019·Application pending·0 cites
- 4164US2005153924A1Antisense modulation of interferon gamma receptor 2Filed 2004·Application pending·0 cites
- 4263US7468356B2Modulation of insulin like growth factor I receptor expressionANTISENSE THERAPEUTICS LTD·Filed 2004·Granted Dec 23, 2008·2 cites·29 claims
- 4363US5856099AAntisense compositions and methods for modulating type I interleukin-1 receptor expressionISIS PHARMACEUTICALS INC·Filed 1996·Granted Jan 5, 1999·18 cites·29 claims
- 4461US8946172B2Method for reducing scarring during wound healing using antisense compounds directed to CTGFMUSTOE THOMAS A·Filed 2009·Granted Feb 3, 2015·1 cites·16 claims
- 4561US2005227938A1Antisense modulation of TFAP2C expressionBENNETT C F·Filed 2004·Application pending·0 cites
- 4661US2003194738A1Antisense oligonucleotide compositions and methods for the modulation of activating protein 1Filed 2003·Application pending·0 cites
- 4760US2009270491A1Modulation of tudor-sn expressionISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4859US8772260B2Methods for inhibiting expression of connective tissue growth factorDEAN NICHOLAS M·Filed 2012·Granted Jul 8, 2014·0 cites·27 claims
- 4959US2019323013A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 5058US8198253B2Compositions and their uses directed to HBXIPDOBIE KENNETH W·Filed 2007·Granted Jun 12, 2012·0 cites·18 claims
Showing the top 50 of 137 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nicholas M. Dean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →